| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |